Epidemiological study of Enterobacteriaceae resistance to colistin in Sfax (Tunisia)

Medecine et Maladies Infectieuses

Volumn 42, Issue 6, 2012, Pages 256-263

  Mezghani Maalej, S ^a   Rekik Meziou, M ^a   Mahjoubi, F ^a   Hammami, A ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

Colistin; Enterobacteriaceae; Resistance

Indexed keywords

CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; FURAN DERIVATIVE; GENTAMICIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE TYPING; BACTERIUM ISOLATE; CLONE; CONTROLLED STUDY; DRUG EXPOSURE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; EPIDEMIOLOGICAL DATA; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; TREND STUDY; TUNISIA; URINALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COLISTIN; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUNISIA; YOUNG ADULT;

EID: 84862997692     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2012.04.008     Document Type: Article

References (39)

1. Falagas M.E., Kasiakou S.K. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis 2005, 40:1333-1341.
2. Li J., Nation R.L., Milne R.W., Turnidge J.D., Coulthard K. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 2005, 25:11-25.
3. Frasca D., Dahyot-Fizelier C., Mimoz O. La colistine en Reanimation. Réanimation 2008, 17:251-258.
4. Ganapathy H., Pal S.K., Teare L., Dziewulski Use of colistin in treating multi-resistant Gram-negative organisms in a specialised burns unit. Burns 2010, 36:522-527.
5. Kallel H., Bahloul M., Hergafi L., Akrout M., Ketata W., Chelly H., et al. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU. Int J Antimicrob Agents 2006, 28:366-369.
6. Koomanachai P., Tiengrim, Kiratisin P., Thamlikitkul V. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomons aeruginosa and Acinetobacter baumannii in Siriraj hospital, Bagkok Thailand. Int J Infect Dis 2007, 11:402-406.
7. Li J., Nation R.L., Turnidge J.D., Milne R.W., Coulthard K., Rayner C.R., et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet 2006, 6:589-601.
8. Markou N., Apostolakos H., Koumoudiou C., Athanasiou M., Koutsoukou A., Alamanos I., et al. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Critical Care 2003, 7:R78-R83.
9. Motaouakkil S., Charra B., Hachimi A., Benslama A. Pneumonies nosocomiales à Acinetobacter baumannii multirésistant traitées par colistine et rifampicine. Ann Fr Anesth Reanim 2006, 25:543-544.
10. Falagas M.E., Maraki S., Karageorgopoulos D.E., Kastoris A.C., Mavromanolakis E., Samonis G. Antimicrobial susceptibility of multidrug resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin. Int J Antimicrob Agents 2010, 35:240-243.
11. Ko K.S., Suh J.Y., Kwon K.T., Jung S.I., Park K.H., Kang C.I., et al. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother 2007, 60:1163-1167.
12. Soussy C J et al. Comité de l'antibiogramme de la Société française de microbiologie Recommandations 2007.(). http://www.sfm.asso.fr/.
13. Falagas M.E., Rafailidis P.I., Matthaiou D.K. Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist Updates 2010, 13:132-138.
14. Gales A.C., Jones R.N., Sader H.S. Global assessment of the antimicrobial activity of polymyxin B against 54731 clinical isolates of Gram-negative bacilli: report from the Sentry antimicrobial surveillance programme (2001-2004). Clin Microbiol Infect 2006, 12:315-321.
15. Hawser S.P. Susceptibility of Klebsiella pneumoniae clinical isolates from 2007 to 2009 to colistin and comparator antibiotics [letter]. Int J Antimicrob Agents 2010, 36:383-389.
16. Johansen H.K., Moskowitz S.M., Ciofu O., Pressler T., Hoiby N. Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J Cyst Fibros 2008, 7:391-397.
17. Landman D., Bratu S., Alam M., Quale J. Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B. J Antimicrob Chemother 2005, 55:954-957.
18. Landman D., Bratu S., Kochar S., Panwar M., Trehan M., Doymaz M., et al. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn NY. J Antimicrob Chemother 2007, 60:78-82.
19. Souli M., Galani I., Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Eurosurveillance 2008, 13:1-11.
20. Antoniadou A., Kontopidou F., Poulakou G., Koratzanis E., Galani I., Papadomichelakis E., et al. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother 2007, 59:786-790.
21. Falagas M.E., Rafailidis P.I., Matthaiou D.K., Virtzili S., Nikita D., Michalopoulous A. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int J Antimicrob Agents 2008, 32:450-454.
22. Kontopoulou K., Protonotariou E., Vasilakos K., Kriti M., Koteli A., Antoniadou E., et al. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 β-lactamse resistant to colistin. J Hospit Infect 2010, 76:70-73.
23. Matthaiou D.K., Michalopoulos A., Rafailidis P., Karageorgopoulos D., Papaioannou V., Ntani G., et al. Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: a matched case-control study. Crit Care Med 2008, 36:807-811.
24. Suh J.Y., Son J.S., Chung D.R., Peck K.R., KO K.S., Song J.H. Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea. Antimicrob Agents Chemother 2010, 54:560-562.
25. Thiolas A., Bollet C., Scola B.L., Raoult D., Pagès J.M. Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient. Antimicrob Agents Chemother 2005, 49:1354-1358.
26. Falagas M.E., Bliziotis I.A., Kasiakou S.K., Samonis G., Athanassopoulou P., Michalopoulos A. Outcome on infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis 2005, 5:24.
27. Tan T.Y., Ng S.Y. The in-vitro activity of colistin in Gram-negative bacteria. Singapore Med J 2006, 47:621-624.
28. Sader H.S., Farrell D.J., Jones R.N. Susceptibility of Klebsiella spp. to colistin and polymyxin B: results from the Sentry antimicrobial surveillance Programm (2006-2009) [letter]. Int J Antimicrob Agents 2011, 37:174-185.
29. Zarkotou O., Pournaras S., Voulgari E., Curysos G., Prekates A., Voutsinas D., et al. Risk factors and outcomes associated with acquisition of colistin-resistant KPC-producing Klebsiella pneumoniae: a matched case-control study. J Clin Microbiol 2010, 48:2271-2274.
30. Hawley J.S., Murray C.K., Jorgensen J.H. Colistin heteroresistance in Acinetobacter and its association with previous Colistin therapy. Antimicrob Agents Chemother 2008, 25:351-352.
31. Beno P., Krcmery V., Demitrovicova A. Bacteraemia in cancer patients caused by colistin-resistant Gram-negative bacilli after previous exposure to ciprofloxacin and/or colistin. Clin Microbiol Infect 2006, 12:497-498.
32. Hernan R.C., Karina B., Gabriela G., Marcela N., Carlos V., Angela F. Selection of colistin resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroressitance to colistin. Diag Microbiol Infect Dis 2009, 65:188-191.
33. Kallel H., Bahloul M., Ksibi H., Dammak H., Chelly H., Ben Hamida C., et al. Prevalence of hospital-acquired infection in a Tunisian hospital. J Hospital Infect 2005, 59:343-347.
34. Mkaouar D., Mahjoubi F., Mezghani S., Znazen A., Ktari S., Hammami A. Etude de la résistance des entérobactéries aux céphalosporines de troisième génération dans les hôpitaux de Sfax Tunisie (1999-2005). Med Mal Infect 2008, 38:293-298.
35. Lee J., Patel G., Huprikar S., Calfee D.P., Jenkins S.G. Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection. J Clin Microbiol 2009, 47:1611-1612.
36. Poudyal A., Howden B.P., Bell J.M., Gao W., Owen R.J., Turnidge J.D., et al. In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae. J Antimicrob Chemother 2008, 62:1311-1318.
37. Li J., Rayner C.R., Nation R.L., Owen R.J., Spelman D., Tan K.E., et al. Hetero-resistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2006, 50:2946-2950.
38. Lo-Ten-Foe J.R., Smet A.M., Diederen B.M., Kluytmans J.A., Keulen P.H. Comparative evaluation of the VITEK2, disk diffusion Etest, Broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother 2007, 51:3726-3730.
39. Yau W., Owen R.J., Poudyal A., Bell J.M., Turnidge J.G., Yu H.H., et al. Colistin hetero-resistant in multidrug-resistant Acinetobacter baumannii clinical isolates from the western pacific region in the Sentry antimicrobial surveillance programe. J Infect 2009, 58:138-144.